Clarrie is a 21-year-old working full-time as a receptionist.

She presents with pain in her hands and fingers bilaterally, which has been worsening over the past week.

The pain is now affecting all

Patients who respond well to programmed cell death protein 1 (PD-1) inhibitor therapy for cancer, may be at increased risk of developing arthritis as an adverse effect, an Australian study suggests.

For the first time, US guidelines are recommending treatment-naive patients with psoriatic arthritis be prescribed a tumour necrosis factor alpha (TNF-alpha) inhibitor as first-line treatment.

TNF

Donald is a 43-year-old secondary school teacher who presents with severe pain in his right groin.

The pain has developed quite quickly over the past month or so, and is now limiting his ability to

Women with systemic lupus erythematosus (SLE) have a risk of cardiovascular disease events some seven times higher than a standard risk score would predict, a UK study shows.

The 124 patients with

Patients with psoriatic arthritis and enthesitis are missing the opportunity to improve their condition using biological disease-modifying anti-rheumatic drugs (bDMARDs), because of current PBS rules,

Tenosynovitis and synovitis are the first signs of inflammation in a joint  affected by rheumatoid arthritis (RA), with osteitis and erosion coming later, according to an MRI study.

The study of 31

Children with juvenile idiopathic arthritis being treated at Australia’s largest paediatric rheumatology clinic have high rates of remission at 12 months, according to study results.

But the analysis

A large real-world study of patients with rheumatic disease who switched to a biosimilar brand of etanercept has found no major safety events or negative impact on disease activity.

The Danish